Toronto Dominion Bank

Toronto Dominion Investments LLC redeemed 990 Muni-MultiMode Preferred Shares from abrdn National Municipal Income Fund for $100,136.68 per share.

Toronto Dominion entities report the redemption of Variable Rate Demand Preferred Shares in Nuveen New Jersey Quality Municipal Income Fund.

Toronto Dominion Investments, Inc. disposed of 364 Variable Rate Muni Term Preferred Shares of Invesco Municipal Trust through an issuer redemption.

Toronto Dominion Investments, Inc., a 10% owner of BlackRock MuniYield New York Quality Fund, Inc., has disposed of 467 Variable Rate Demand Preferred Shares due to a redemption by the issuer.

TD Bank and its affiliates are seeking an exemption from certain provisions of the Investment Company Act of 1940 due to recent anti-money laundering (AML) compliance failures.

Toronto Dominion Investments, Inc. acquired 600 Series B MuniFund Preferred Shares from Nuveen Enhanced High Yield Municipal Bond Fund on September 5, 2024, increasing its holdings.

Toronto Dominion Bank has filed its Form 13F for the quarter ending March 31, 2026, reporting a total of 3,578 holdings valued at $69,732,163,985.

Toronto Dominion Bank has filed its 13F-HR report, revealing $64.49 billion in equity holdings across 3,359 positions for the quarter ended September 30, 2025.

Toronto Dominion Bank has filed its Q2 2025 13F-HR report, revealing a diversified equity portfolio valued at over $60 billion across more than 3,000 positions.

Toronto Dominion Bank's latest 13F filing discloses over $51 billion in managed securities across 2,768 positions as of March 31, 2025.

Toronto Dominion Bank's latest 13F filing reveals significant holdings valued at over $63.3 billion as of December 31, 2024, with major positions in technology, finance, and energy sectors.

Toronto Dominion Bank's latest 13F filing reveals a diverse portfolio with substantial holdings in technology, finance, and resource companies as of December 31, 2024.

The Toronto-Dominion Bank has substantially reduced its beneficial ownership in The Charles Schwab Corporation to 0.1% through a recent secondary public offering and a share repurchase agreement.

The Toronto-Dominion Bank and TD Securities Inc. have filed a Schedule 13G, reporting beneficial ownership of 6.9% of UroGen Pharma Ltd.'s ordinary shares.

The Toronto-Dominion Bank and TD Securities Inc. have updated their beneficial ownership filing for Stoke Therapeutics, Inc., reporting a combined 4.9% stake.

Vanguard Capital Management has reported beneficial ownership of 5% of Toronto-Dominion Bank's common stock as of June 30, 2026.

The Toronto-Dominion Bank and its subsidiary TD Securities Inc. have reported beneficial ownership of 5.4% of Stoke Therapeutics, Inc. common stock as of March 31, 2026.

The Toronto-Dominion Bank and TD Securities Inc. have filed a Schedule 13G, reporting beneficial ownership of 5.4% of UroGen Pharma Ltd.'s ordinary shares as of March 31, 2026.

The Toronto-Dominion Bank has filed a Schedule 13G, reporting beneficial ownership of 3,025,945 shares, or 3.7%, of PTC Therapeutics, Inc. common stock as of March 31, 2026.